- Patients
- Clinical Research
- Clinical trials
- 102 Hummingbird
2024-09-24T05:40:03.512Z
102 Hummingbird
102 Hummingbird
Solid tumors
A study of an Anti-HER3 Antibody, HMBD-001, With or without Chemotherapy in Patients with Solid Tumours Harboring an NRG1 Fusion or HER3 Mutation Phase 1b HER3 inhibitor NRG1 fusions (panc, NSCLC) and SCC studies
A study of an Anti-HER3 Antibody, HMBD-001, With or without Chemotherapy in Patients with Solid Tumours Harboring an NRG1 Fusion or HER3 Mutation Phase 1b HER3 inhibitor NRG1 fusions (panc, NSCLC) and SCC studies
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Basket - Solid Tumours
Study Phase
1b
Trial registration
Number: NCT05919537
https://clinicaltrials.gov/study/NCT05919537?term=HMBD-001-102%20&rank=1
GenesisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)